Vasoactive-inotropic Support and Levosimendan Use After Lung Transplantation

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions

Lung Transplant; Complications

Interventions

DRUG

Epinephrine Norepinephrine Dobutamine Dopamine Levosimendan

Vasoactive-inotropic drugs were administered according to clinical decision of the doctor in charge.

Trial Locations (1)

Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, Milan

All Listed Sponsors

lead

Policlinico Hospital

OTHER

NCT05702333 - Vasoactive-inotropic Support and Levosimendan Use After Lung Transplantation | Biotech Hunter | Biotech Hunter